- Home
- RCUS vs VRNT Comparison
RCUS vs VRNT Comparison
Compare RCUS & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- VRNT
- Stock Information
- Founded
- RCUS 2015
- VRNT 1994
- Country
- RCUS United States
- VRNT United States
- Employees
- RCUS N/A
- VRNT N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- VRNT EDP Services
- Sector
- RCUS Health Care
- VRNT Technology
- Exchange
- RCUS Nasdaq
- VRNT Nasdaq
- Market Cap
- RCUS 906.4M
- VRNT 1.1B
- IPO Year
- RCUS 2018
- VRNT N/A
- Fundamental
- Price
- RCUS $9.32
- VRNT $21.43
- Analyst Decision
- RCUS Buy
- VRNT Buy
- Analyst Count
- RCUS 8
- VRNT 7
- Target Price
- RCUS $20.86
- VRNT $31.71
- AVG Volume (30 Days)
- RCUS 721.6K
- VRNT 2.1M
- Earning Date
- RCUS 08-07-2025
- VRNT 09-03-2025
- Dividend Yield
- RCUS N/A
- VRNT N/A
- EPS Growth
- RCUS N/A
- VRNT 79.53
- EPS
- RCUS N/A
- VRNT 0.84
- Revenue
- RCUS $141,000,000.00
- VRNT $896,006,000.00
- Revenue This Year
- RCUS N/A
- VRNT $7.73
- Revenue Next Year
- RCUS $28.73
- VRNT $5.47
- P/E Ratio
- RCUS N/A
- VRNT $25.84
- Revenue Growth
- RCUS N/A
- VRNT N/A
- 52 Week Low
- RCUS $6.50
- VRNT $14.15
- 52 Week High
- RCUS $18.98
- VRNT $37.31
- Technical
- Relative Strength Index (RSI)
- RCUS 55.03
- VRNT 57.99
- Support Level
- RCUS $9.14
- VRNT $21.19
- Resistance Level
- RCUS $10.34
- VRNT $22.68
- Average True Range (ATR)
- RCUS 0.48
- VRNT 0.75
- MACD
- RCUS 0.07
- VRNT -0.05
- Stochastic Oscillator
- RCUS 48.91
- VRNT 64.63
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.